Toll Like Receptors in systemic sclerosis: an emerging target

Steven O'Reilly

Research output: Contribution to journalArticlepeer-review

24 Citations (Scopus)
7 Downloads (Pure)


Pattern Recognition Receptors are critical receptors that elicit an immune response upon their activation that culminates in activation of NF-KB and cytokine secretion. Key among these receptors are the Toll-Like Receptors (TLRs). These evolutionary conserved receptors form a key part in the defence against various pathogens and comprise a key part of the innate immune system. Systemic sclerosis is an autoimmune disease in which a breach of tolerance has occurred and leads to fulminant autoimmunity, dysregulated cytokines, pro-fibrotic mediators and activation of fibroblasts leading to fibrosis via collagen deposition. It has become apparent in recent years that the innate immune system and specifically TLRs are important in disease pathogenesis; responding to internal ligands to initiate an innate immune response ultimately leading to release of a variety of factors that initiate and perpetuate fibrosis. This review will examine the recent evidence of TLR signalling in systemic sclerosis and the internal danger associated molecules that may mediate the fibrotic cascade. Evaluation of their contribution to disease in systemic sclerosis and possible therapeutic targeting will be discussed.
Original languageEnglish
Pages (from-to)2-8
JournalImmunology Letters
Early online date6 Sept 2017
Publication statusPublished - 1 Mar 2018


Dive into the research topics of 'Toll Like Receptors in systemic sclerosis: an emerging target'. Together they form a unique fingerprint.

Cite this